Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12590 | 30373519 | BMC Cardiovasc Disord | The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET/CT study. | 2018 | Details |
| A12612 | 30364513 | J Med Life | The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease. | 2018 | Details |
| A12613 | 30363947 | Oxid Med Cell Longev | Treatment of NASH with Antioxidant Therapy: Beneficial Effect of Red Cabbage on Type 2 Diabetic Rats. | 2018 | Details |
| A12634 | 30358050 | Liver Int | Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis. | 2018 | Details |
| A12641 | 30353682 | J Diabetes Investig | Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals. | 2018 | Details |
| A12642 | 30353552 | Aliment Pharmacol Ther | The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. | 2018 | Details |
| A12647 | 30349997 | Sleep Breath | The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea. | 2018 | Details |
| A12650 | 30347513 | Liver Int | Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A12659 | 30341767 | Hepatology | Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12660 | 30341231 | Postgrad Med J | Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. | 2018 | Details |
| A12663 | 30338914 | J Cell Mol Med | MiR-17 family-mediated regulation of Pknox1 influences hepatic steatosis and insulin signaling. | 2018 | Details |
| A12671 | 30335697 | Transplantation | Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. | 2019 | Details |
| A12674 | 30334985 | Medicine (Baltimore) | Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease: A population-based retrospective cohort study. | 2018 | Details |
| A12690 | 30325900 | Med Sci Monit | Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A12707 | 30319417 | Front Pharmacol | The Role of Gut Microbiota in Atherosclerosis and Hypertension. | 2018 | Details |
| A12708 | 30318957 | Arch Physiol Biochem | High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats. | 2018 | Details |
| A12722 | 30315891 | Diabetes Metab | Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. | 2018 | Details |
| A12732 | 30312631 | Toxicol Appl Pharmacol | Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes. | 2018 | Details |
| A12738 | 30309884 | J Investig Med | Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus. | 2018 | Details |
| A12741 | 30308578 | Eur J Gastroenterol Hepatol | Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies. | 2019 | Details |
| A12758 | 30299993 | Expert Opin Pharmacother | Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease. | 2018 | Details |
| A12775 | 30292582 | Rev Gastroenterol Mex (Engl Ed) | Prevalence of hepatic steatosis and its relation to liver function tests and lipid profile in patients at medical check-up. | 2018 | Details |
| A12783 | 30288767 | Aliment Pharmacol Ther | Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany. | 2018 | Details |
| A12785 | 30288477 | Hepatol Commun | Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. | 2018 | Details |
| A12801 | 30282916 | Diseases | Anti-Diabetic Medications for the Pharmacologic Management of NAFLD. | 2018 | Details |
| A12805 | 30275460 | Nat Rev Endocrinol | The role of hypoxia-inducible factors in metabolic diseases. | 2018 | Details |
| A12807 | 30274911 | Clin Res Hepatol Gastroenterol | Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes. | 2018 | Details |
| A12819 | 30269815 | Biochem Biophys Res Commun | Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet. | 2018 | Details |
| A12830 | 30264828 | AIDS Rev | Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection | 2018 | Details |
| A12836 | 30261661 | Int J Mol Sci | Fc Gamma Receptor IIb Expressed in Hepatocytes Promotes Lipid Accumulation and Gluconeogenesis. | 2018 | Details |
| A12837 | 30261472 | Atherosclerosis | Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population. | 2018 | Details |
| A12842 | 30259374 | Adv Exp Med Biol | Circular RNAs in Metabolic Diseases. | 2019 | Details |
| A12849 | 30257633 | Med J Aust | The gut microbiota: cause and cure of gut diseases. | 2018 | Details |
| A12857 | 30254005 | Acad Radiol | Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight Individuals. | 2018 | Details |
| A12858 | 30253056 | Liver Int | Cardiovascular risk factors in non-alcoholic fatty liver disease. | 2018 | Details |
| A12863 | 30250238 | Sci Rep | Human hepatic 3D spheroids as a model for steatosis and insulin resistance. | 2018 | Details |
| A12865 | 30249980 | Diseases | Judicious Use of Lipid Lowering Agents in the Management of NAFLD. | 2018 | Details |
| A12888 | 30241400 | Int J Mol Sci | Metformin: An Old Drug with New Applications. | 2018 | Details |
| A12890 | 30239032 | J Clin Lab Anal | Liver stiffness assessed by transient elastography as a potential indicator of chronic kidney disease in patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A12902 | 30234161 | Open Med (Wars) | Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A12911 | 30229578 | Endocrinol Metab (Seoul) | Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A12923 | 30225267 | J Diabetes Res | Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats. | 2018 | Details |
| A12950 | 30212992 | Medicine (Baltimore) | Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitus. | 2018 | Details |
| A12975 | 30200724 | Zhongguo Zhong Yao Za Zhi | [Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota]. | 2018 | Details |
| A13001 | 30186875 | J Diabetes Res | Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats. | 2018 | Details |
| A13004 | 30185840 | Eur J Clin Nutr | Body composition and insulin resistance in children. | 2018 | Details |
| A13010 | 30182761 | Endocr Res | A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities. | 2018 | Details |
| A13020 | 30178600 | Diabetes Obes Metab | Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease. | 2018 | Details |
| A13028 | 30174213 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. | 2018 | Details |
| A13040 | 30170220 | Atherosclerosis | Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease. | 2018 | Details |
| A13075 | 30149145 | Diabetes Metab | SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes. | 2018 | Details |
| A13082 | 30144554 | J Hepatol | The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. | 2018 | Details |
| A13101 | 30138983 | Zhonghua Yi Xue Za Zhi | [The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults]. | 2018 | Details |
| A13117 | 30132035 | Diabetologia | SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases. | 2018 | Details |
| A13132 | 30122876 | World J Gastroenterol | Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. | 2018 | Details |
| A13136 | 30121811 | Dig Dis Sci | Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13138 | 30120579 | Curr Diab Rep | Emerging Role of AMPK in Brown and Beige Adipose Tissue (BAT): Implications for Obesity, Insulin Resistance, and Type 2 Diabetes. | 2018 | Details |
| A13148 | 30115487 | J Diabetes Complications | Body fat, metabolic syndrome and hyperglycemia in South Asians. | 2018 | Details |
| A13151 | 30113367 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. | 2018 | Details |
| A13174 | 30100243 | Mol Metab | Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context. | 2018 | Details |
| A13177 | 30099414 | Wiad Lek | Pathogenesis of insulin resistance in pregnant women with obesity. | 2018 | Details |
| A13182 | 30097139 | J Psychosom Res | Quality of life in patients with nonalcoholic fatty liver disease: A systematic review. | 2018 | Details |
| A13189 | 30094399 | Hepatol Commun | Association of Hepatic Steatosis With Subclinical Atherosclerosis: Systematic Review and Meta-Analysis. | 2018 | Details |
| A13192 | 30092609 | Obes Rev | The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis. | 2018 | Details |
| A13196 | 30090738 | Indian J Endocrinol Metab | Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2020 | Details |
| A13200 | 30089409 | Ann Clin Biochem | Elevated serum cytokeratin-18 concentration in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease. | 2018 | Details |
| A13202 | 30087027 | Hepatobiliary Pancreat Dis Int | Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population. | 2018 | Details |
| A13203 | 30086995 | Psychosomatics | Cognitive Performance in Individuals With Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus. | 2018 | Details |
| A13214 | 30079133 | World J Hepatol | Associations between nonalcoholic fatty liver disease and ischemic stroke. | 2018 | Details |
| A13223 | 30075812 | BMC Res Notes | Survey on knowledge of non-alcoholic fatty liver disease (NAFLD) among doctors in Sri Lanka: a multicenter study. | 2018 | Details |
| A13224 | 30075518 | Medicine (Baltimore) | Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016. | 2018 | Details |
| A13229 | 30073778 | J Diabetes | Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial. | 2018 | Details |
| A13230 | 30073766 | Diabetes Obes Metab | Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study. | 2018 | Details |
| A13245 | 30066148 | Diabetologia | Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial. | 2018 | Details |
| A13248 | 30065557 | World J Gastroenterol | Considerations for bariatric surgery in patients with cirrhosis. | 2018 | Details |
| A13257 | 30060948 | Biochem Biophys Res Commun | Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD. | 2018 | Details |
| A13260 | 30060614 | Nutrients | French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES. | 2018 | Details |
| A13266 | 30060179 | J Clin Endocrinol Metab | Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes. | 2018 | Details |
| A13281 | 30052309 | Diabetes Metab Res Rev | Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. | 2018 | Details |
| A13291 | 30048367 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated? | 2018 | Details |
| A13293 | 30047462 | Chin J Nat Med | Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats. | 2018 | Details |
| A13297 | 30042872 | Am J Nucl Med Mol Imaging | Hepato-splenic axis: hepatic and splenic metabolic activities are linked. | 2018 | Details |
| A13321 | 30032630 | Rev Esp Enferm Dig | Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease. | 2018 | Details |
| A13326 | 30030064 | Life Sci | Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients. | 2018 | Details |
| A13327 | 30029691 | Cardiovasc Diabetol | Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats. | 2018 | Details |
| A13339 | 30025558 | Biomed Environ Sci | Association between IgG N-glycans and Nonalcoholic Fatty Liver Disease in Han Chinese. | 2018 | Details |
| A13340 | 30025200 | Liver Int | Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study. | 2018 | Details |
| A13367 | 30014320 | Hormones (Athens) | Sarcopenic obesity. | 2018 | Details |
| A13377 | 31595238 | Porto Biomed J | NAFLD and cardiovascular disease. | 2018 | Details |
| A13380 | 30009716 | Endocr Metab Immune Disord Drug Targets | Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation. | 2019 | Details |
| A13402 | 29994981 | Transplantation | Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. | 2019 | Details |
| A13405 | 29992886 | Curr Vasc Pharmacol | Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives. | 2019 | Details |
| A13406 | 29992631 | J Eur Acad Dermatol Venereol | Position statement for the management of comorbidities in psoriasis. | 2018 | Details |
| A13412 | 29990865 | Biomed Pharmacother | Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway. | 2018 | Details |
| A13419 | 29988867 | World J Transplant | Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review. | 2018 | Details |
| A13423 | 29984415 | Aliment Pharmacol Ther | Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors. | 2018 | Details |
| A13429 | 29980170 | BMC Gastroenterol | Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal. | 2018 | Details |
| A13434 | 29975579 | Endocr Pract | Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China. | 2018 | Details |
| A13443 | 29971527 | Diabetologia | Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. | 2018 | Details |
| A13463 | 29959534 | Med Mol Morphol | Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes. | 2018 | Details |